Literature DB >> 2550152

DNA damage, cytotoxicity and free radical formation by mitomycin C in human cells.

L Dusre1, J M Covey, C Collins, B K Sinha.   

Abstract

Mitomycin C (MMC), a quinone-containing antitumor drug, has been shown to alkylate DNA and to form DNA cross-links. The ability of MMC to alkylate O6-guanine and to form interstrand cross-links (ISC) has been studied using Mer+ and Mer- human embryonic cells. Mer+ (IMR-90) cells have been reported to contain an O6-alkylguanine transferase enzyme and are, in general, more resistant to alkylating agents than the Mer- (VA-13) cell line, which is deficient in the repair of O6-lesions in DNA. Studies reported here show that MMC is more cytotoxic to VA-13 cells compared to IMR-90 cells. The alkaline elution technique was used to quantify MMC-induced ISC, and double strand breaks (DSB) in these cells. The drug-dependent formation of DSB was significantly lower in IMR-90 cells than in VA-13 cells. In contrast, no significant difference in cross-linking could be detected at the end of 2-h drug treatment. Although a small increase in cross-link frequency was observed in the VA-13 cell line relative to the IMR-90 cell line 6 h post drug treatment, it is not clear whether monoalkylated adducts at the O6-position are formed, and contribute to cross-link formation for differential cytotoxicity in VA-13 cells. Electron spin resonance and spin-trapping technique were used to detect the formation of hydroxyl radical from MMC-treated cells. Our studies show that MMC significantly stimulated the formation of hydroxyl radical in VA-13 cells, but not in the IMR-90 cells. The formation of the hydroxyl radical was inhibited by superoxide dismutase (SOD) and catalase. In addition, the presence of these enzymes partially protected VA-13 cells from MMC toxicity but not IMR-90 cells. Further studies indicated that the decreased free radical formation and resistance to MMC may be due to the increased activities of catalase and glutathione transferase in the IMR-90 cell line. These results suggest that MMC-dependent DNA damage (alkylation and DNA DSB) and the stimulation of oxy-radical formation may play critical roles in the determination of MMC-induced cell killing.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550152     DOI: 10.1016/0009-2797(89)90090-2

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  16 in total

1.  DNA Damage Does Not Cause BrdU Labeling of Mouse or Human β-Cells.

Authors:  Rohit B Sharma; Christine Darko; Xiaoying Zheng; Brian Gablaski; Laura C Alonso
Journal:  Diabetes       Date:  2019-03-04       Impact factor: 9.461

2.  Postoperative peritoneal adhesion: an update on physiopathology and novel traditional herbal and modern medical therapeutics.

Authors:  Setareh Soltany
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-09-26       Impact factor: 3.000

Review 3.  Prevention of esophageal strictures after endoscopic submucosal dissection.

Authors:  Shinichiro Kobayashi; Nobuo Kanai; Takeshi Ohki; Ryo Takagi; Naoyuki Yamaguchi; Hajime Isomoto; Yoshiyuki Kasai; Takahiro Hosoi; Kazuhiko Nakao; Susumu Eguchi; Masakazu Yamamoto; Masayuki Yamato; Teruo Okano
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

4.  Treatment of pea (Pisum sativum L.) protoplasts with DNA-damaging agents induces a 39-kilodalton chloroplast protein immunologically related to Escherichia coli RecA.

Authors:  H Cerutti; H Z Ibrahim; A T Jagendorf
Journal:  Plant Physiol       Date:  1993-05       Impact factor: 8.340

5.  Mitigating effect of Indian propolis against mitomycin C induced bone marrow toxicity.

Authors:  Sandhya Kumari; Prashantha Naik; B L Vishma; Sujith Raj Salian; Raviraj Anand Devkar; Saleemulla Khan; Srinivas Mutalik; Guruprasad Kalthur; Satish Kumar Adiga
Journal:  Cytotechnology       Date:  2015-11-21       Impact factor: 2.058

6.  Meayamycin inhibits pre-messenger RNA splicing and exhibits picomolar activity against multidrug-resistant cells.

Authors:  Brian J Albert; Peter A McPherson; Kristine O'Brien; Nancy L Czaicki; Vincent Destefino; Sami Osman; Miaosheng Li; Billy W Day; Paula J Grabowski; Melissa J Moore; Andreas Vogt; Kazunori Koide
Journal:  Mol Cancer Ther       Date:  2009-08-11       Impact factor: 6.261

7.  A Model for NAD(P)H:Quinoneoxidoreductase 1 (NQO1) Targeted Individualized Cancer Chemotherapy.

Authors:  Asher Begleiter; Nadia El-Gabalawy; Laurie Lange; Marsha K Leith; Lynn J Guziec; Frank S Guziec
Journal:  Drug Target Insights       Date:  2009-01-15

8.  Bacillus subtilis SbcC protein plays an important role in DNA inter-strand cross-link repair.

Authors:  Judita Mascarenhas; Humberto Sanchez; Serkalem Tadesse; Dawit Kidane; Mahalakshmi Krisnamurthy; Juan C Alonso; Peter L Graumann
Journal:  BMC Mol Biol       Date:  2006-06-16       Impact factor: 2.946

9.  YQ36: a novel bisindolylmaleimide analogue induces KB/VCR cell death.

Authors:  Ji Cao; Lei Zhang; Qing Ye; Xinglu Zhou; Jianshu Lou; Difeng Zhu; Yongzhou Hu; Qiaojun He; Bo Yang
Journal:  J Biomed Biotechnol       Date:  2010-01-04

10.  A novel topoisomerase I inhibitor DIA-001 induces DNA damage mediated cell cycle arrest and apoptosis in cancer cell.

Authors:  Jiaqi Liu; Guohe Geng; Guang Liang; Ling Wang; Kuntian Luo; Jian Yuan; Shiguang Zhao
Journal:  Ann Transl Med       Date:  2020-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.